All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
The Lupus Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Introducing
Now you can personalise
your Lupus Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe Lupus Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lupus Hub cannot guarantee the accuracy of translated content. The Lupus Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Validation of childhood lupus low disease activity state definition
Bookmark this article
Childhood-onset systemic lupus erythematosus (cSLE) has a more severe disease course compared to adult-onset SLE.1 The Lupus Low Disease Activity State (LLDAS) seems to be realistic treat-to-target approach in these patients.1 An international taskforce developed an adapted LLDAS for cSLE called childhood Lupus Low Disease Activity State (cLLDAS) due to an unmet need for a cSLE-specific definition in this population.2
Bergkamp et al.1 recently published an article in Clinical Immunology presenting the first study to validate the new cLLDAS definition in a real-life cohort of cSLE patients.1 Here, we summarize the key findings.
Methods1
-
The new cLLDAS definition was retrospectively applied to prospectively collected data from the longitudinal, real-life cSLE cohort.
-
The objectives of the study were to:
-
-
compare the time to achieve first adult LLDAS (aLLDAS) vs cLLDAS;
-
Assess if patients with cSLE could maintain cLLDAS for ≥50% of follow-up time (cLLDAS-50); and
-
assess the predictors for cLLDAS-50 and occurrence of damage using univariate logistic regression analysis.
-
Key findings1
-
A total of 50 patients with cSLE were included; 86% were females and mean age at diagnosis was 14 years.
cLLDAS
-
Each patient attained aLLDAS and cLLDAS at least once during their follow-up.
-
Mean time to attain first aLLDAS and cLLDAS was 8.2 and 9.0 months, respectively.
-
-
However, this difference was only due to one patient.
-
-
In 22 of the 42 patients, the mean delay to achieve first cLLDAS due to steroid dosage was 6.2 months.
-
Median time spent in first cLLDAS was 3 months, with 78% patients not remaining in first cLLDAS.
cLLDAS-50
-
cLLDAS-50 was maintained in 58% of patients.
-
The predictors for attaining cLLDAS-50, as per univariate analysis, are depicted in Figure 1A.
-
-
In the multivariate analysis, a longer time from diagnosis to first cLLDAS (Odds ratio [OR], 0.828; p = 0.030) and higher number of flares (OR, 0.305; p = 0.04) were negative predictors for attaining cLLDAS-50.
-
Damage
-
Damage occurred in 34% of patients with a median follow-up of 3.1 years from diagnosis, with 64.7% experiencing damage within ≤1 year after diagnosis.
-
The predictors of damage, as per univariate analysis, are depicted in Figure 1B.
-
-
The significance of these predictors for damage disappeared in the multivariate model.
-
Figure 1. Univariate logistic regression analysis of variables associated with A attainment of cLLDAS-50 and B occurrence of damage*
CI, confidence interval; cLLDAS, childhood lupus low disease activity state; OR, odds ratio; PGA, physician global assessment; SLEDAI, Systemic Lupus Erythematosus Activity Index-2 K.
*Data from Bergkamp, et al.1
|
Key learnings |
|
- Bergkamp SC, Kanagasabapathy T, Gruppen MP, et al. First validation of the childhood lupus low disease activity state (cLLDAS) definition in a real-life longitudinal cSLE cohort. Clin Immunol. 2024. Online ahead of print. DOI: 10.1016/j.clim.2024.110172
- Smith EMD, Aggarwal A, Ainsworth J, et al. PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). Clin Immunol. 2023;250:109296. DOI: 10.1016/j.clim.2023.109296
More about...
Related articles
Newsletter
Subscribe to get the best content related to lupus delivered to your inbox